The total return over the past 12 months is +23.49% vs. +16.94% for the S&P 500. So far it's up +42.40% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +23.49% | (33.99%) | (43.17%) | N/A | N/A | N/A |
| Total Return CAGR | +23.49% | (33.99%) | (43.17%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
PMV Pharmaceuticals, Inc. (PMVP)
| Year | Start price | End price | PMVP Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.25 | $1.78 | +42.40% | +14.51% | +27.89% |
| 2025 | $1.51 | $1.25 | (17.22%) | +17.72% | (34.94%) |
| 2024 | $3.10 | $1.51 | (51.29%) | +24.89% | (76.18%) |
| 2023 | $8.70 | $3.10 | (64.37%) | +26.19% | (90.56%) |
| 2022 | $23.10 | $8.70 | (62.34%) | (18.17%) | (44.17%) |
| 2021 | $61.51 | $23.10 | (62.45%) | +28.74% | (91.19%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
